The World Congress on Lung Cancer in Seoul has just concluded, and the insightful Dr. Chul Kim of Georgetown University and Medstar Health joined #HealthcareUnfiltered EXPRESS to share his valuable…
Pranav Rajpurkar, co-founder of A2Z Radiology, joins Healthcare Unfiltered EXPRESS to discuss the current—and future—state of AI in radiology. How will AI transform the field? What will it mean for…
Dr. Gilberto Lopes, senior author on a recent Lancet publication addressing alcohol and cancer, joins the show to share the findings of hs group research, and the broader implications of alcohol and…
Dr. Bishoy Flatas, a pioneer in bladder cancer research at Cornell, joins the show to highlight his work on AI Tumor Twins and his in-silico model for predicting which drugs may be more effective for…
I am joined by the amazing Dr. Paul Richardson from the Dana-Farber Cancer Institute to discuss the SUCCESSOR trial that was presented at EHA. This trial discusses CELMoDs by highlighting a landmark…
Dr. Bruna Pellini of Baptist Health Miami Cancer Institute joins Healthcare Unfiltered EXPRESS to break down the most important lung cancer data presented at ASCO 2026. Together, we discuss the trials…
Dr. Mark Lewis visits Healthcare Unfiltered Express to provide how data presented at major scientific meetings, such as ASCO, needs to be put in context from a patient perspective.
Dr. Saurabh Dahiya from Stanford University explains the recent changes in the FDA recommendations regarding the monitoring program previously mandated for centers delivering CAR-T therapies, and why…
Dr. Jonathan Chen from Stanford visits the Healthcare Unfiltered Express to describe how AI can or maybe cannot aid in complex decision making. This is a must listen episode; get a glimpse of how AI…
Dr. Virginia Kaklamani, world renowned breast cancer specialist and researcher, visits with Healthcare Unfiltered EXPRESS to detail how this class of agents are used in metastatic and early stage…
